We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

Futura Medical

MED3000: more detail on FM57 results

Lighthouse | 02 April 2020

Futura Medical

Encouraging FY19 results and MED3000 update

Lighthouse | 01 April 2020

MaxCyte

Top cancer Advanced Therapy Company partnership

Lighthouse | 24 March 2020

Bonesupport

Accelerated FDA pathway for CERAMENT G

Lighthouse | 23 March 2020

Hutchison China MediTech

Progress suggests that 2020 will be a decisive year

Lighthouse | 04 March 2020

Nexstim

Focussing on strategic priorities

Update | 02 March 2020

Bonesupport

Cementing the foundations for growth

Update | 02 March 2020

Hutchison China MediTech

A wealth of opportunity for surufatinib

Update | 18 February 2020

Futura Medical

MED3000 European regulatory pathway is clearer

Lighthouse | 17 February 2020

BerGenBio

Focused on second-line NSCLC and AML

Update | 12 February 2020
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
171 results found.